Q & A Archives - Page 174 of 199

Q&A with Mark Thomas Financial Stocks & Investment Fund Analyst at Hardman & Co

16th August 2016

Hardman & Co’s Mark Thomas discusses Arbuthnot Banking Group Plc in this exclusive interview with DirectorsTalk

Q&A with Ray Gibbs Chief Executive Officer at Haydale Graphene Industries PLC (LON:HAYD)

12th August 2016

Haydale Graphene Industries’ Ray Gibbs discusses the launch of graphene enhanced PLA filaments for 3D printing in this exclusive interview with DirectorsTalk

Q&A with Philipp Prince Chief Financial Officer at Defenx PLC (LON:DFX)

11th August 2016

Defenx’s Philipp Prince discusses the 900 million Android users at risk of being hacked, what this means to the users and to Defenx and where their product can be purchased from in this exclusive interview with DirectorsTalk

Q&A with Marcus Leaver Chief Executive Officer at Quarto Group Inc (LON:QRT)

10th August 2016

Quarto Group’s Marcus Leaver discusses their half-year results ending 30th June 2016 and their acquisition of beckerandmayer in this exclusive interview with DirectorsTalk

Q&A with Philipp Prince Chief Financial Officer at Defenx PLC (LON:DFX)

3rd August 2016

Defenx’s Philipp Prince discusses their acquisition of Memopal in this exclusive interview with DirectorsTalk

Q&A with Fiorenzo Tagliabue CEO & Cesare Valli MD at SEC SpA (LON:SECG)

27th July 2016

SEC SpA’s Fiorenzo Tagliabue and Cesare Valli discuss their admission to the AIM market on the London Stock Exchange in this exclusive interview with DirectorsTalk

Q&A with Neill Ricketts Chief Executive Officer at Versarien PLC (LON:VRS)

27th July 2016

Versarien’s Neill Ricketts discusses their fully subscribed placing, their supportive shareholders, what the proceeds will be used for and the higher number of opportunities for the business in this exclusive interview with DirectorsTalk

Q&A with Kevin Johnson Chief Executive Officer at Surface Transforms plc (LON:SCE)

25th July 2016

Surface Transforms’ Kevin Johnson discusses their new pre-production (technology development) agreement with a leading German performance car manufacturer in this exclusive interview with DirectorsTalk

CloudTag – Investing in innovation: Q&A with Jeanne Bolger

21st July 2016

Jeanne Bolger has over 25 years of pharmaceutical industry experience in management roles across R&D, Commercial and Business Development. In February 2013, Jeanne started with Johnson & Johnson Innovation –

Q&A with John Blamire Chief Executive Officer at Falanx Group Ltd (LON:FLX)

20th July 2016

Falanx Group’s John Blamire discusses what’s happened since year end 31st March, growth opportunity in the cyber security market and what investors should be looking out for in the coming months in this exclusive interview with DirectorsTalk